Appointment New Patient Appointment or 214-645-8300

Recognized as one of the leading programs of its kind, UT Southwestern Medical Center’s Bone Marrow Transplant Program has performed more than 1,200 bone marrow transplants (also known as stem cell transplants) while achieving the best one-year patient survival rates in North Texas.

Our highly specialized program is part of the Harold C. Simmons Comprehensive Cancer Center, the only National Cancer Institute-designated comprehensive cancer center in North Texas.

COVID-19, Cancer, and Vaccinations: What You Need to Know

Hematologic Malignancies & Bone Marrow Transplantation Program

The Hematologic Malignancies & Bone Marrow Transplantation Program at UT Southwestern provides excellent, compassionate care for patients with all types of blood cancers. From a personalized patient experience to cutting-edge treatments, discover what sets us apart.

Expert Care and Top Accolades

A bone marrow transplant replaces unhealthy bone marrow – the tissue inside bones that produces blood-forming cells ­– with healthy cells that should restore normal blood cell production. Bone marrow transplants are used to treat people with cancers of the blood, bone marrow, and lymph nodes, and other blood and immune disorders.

The Bone Marrow Transplant Program at UT Southwestern is accredited by the Foundation for the Accreditation of Cellular Therapy, which recognizes top-quality patient care. We also have been deemed a national center of excellence by all major national health insurance carriers.

Our experienced physicians, nurses, and other care providers guide patients through every step of the bone marrow transplant process. We strive to deliver the most appropriate and effective care possible, and we’re here to manage care from diagnosis to personalized treatment and beyond. 

UT Southwestern offers CAR-T therapy for the treatment of leukemia, lymphoma, and myeloma. CAR-T is immunotherapy in which a patient’s T-cells, a type of white blood cell, are genetically modified to include a chimeric antigen receptor (CAR) that is designed to bind to specific proteins on cancer cells. This reprograms the T-cells to recognize and attack the patient’s specific cancer. We are an approved site for Yescarta and Kymriah immunotherapies for the treatment of lymphoma. Kymriah can also be used to treat leukemia. We are one of just nine U.S. hospitals participating in the most advanced phases of clinical trials of CAR-T therapy for multiple myeloma.

Our Services

At UT Southwestern, we perform bone marrow transplants for patients ranging in age from early adulthood to their 70s.

UT Southwestern’s Bone Marrow Transplant Program is unique because:

  • Our team is specially trained to care for patients with blood cancers and other blood disorders.
  • Our specialists are leading the way in clinical trials related to blood cancers and bone marrow transplants.
  • We have the leading survival rate for adult allogeneic stem cell (bone marrow) transplants in Texas.
  • We pioneered a transplant process that replaces harmful cells with immune cells engineered to attack diseased cells.
  • We are experts in both autologous (patient’s own cells) and allogeneic (donor cells) transplants.
  • We offer a variety of support services to help patients and families through bone marrow transplantation and beyond. 

Learn more about the procedure.

Helping Dad beat leukemia: Jon and Chuck’s story

Find a Clinical Trial

We have a wide range of clinical trials open to patients with all stages of cancer. Search for opportunities to participate in a cancer study.


Award-Winning Care

We’re one of the world’s top academic medical centers, with a unique legacy of innovation in patient care and scientific discovery.  

Why UT Southwestern


Our secure online portal for patients makes it easy to communicate with your doctor, access test results, and more.

Log In